ArticleArchives of virology2026
Biological risk assessment related to intracerebral injection of TMEV-DA.
Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Theiler's murine encephalomyelitis virus (TMEV) is a natural enteric pathogen of mice that, when injected intracranially, induces a demyelinating disease resembling multiple sclerosis. However, data on viral shedding following intracranial infection are sparse for some strains and entirely absent for others, such as the Daniels strain, making it difficult to accurately assess the biological risks associated with infected animals. In our study, we used a combination of RT-qPCR and immunoassays to evaluate viral shedding and the associated infectious risk. We show that viral RNA is detectable in the feces of some mice and that the proportion of shedding animals varies by mouse line. Nevertheless, none of the sentinel mice exposed to soiled bedding from infected animals exhibited seroconversion, indicating that the viral particles are either present at levels below the minimum infectious dose or represent residual, non-infectious material rather than active, transmission-competent virus.
Indexed as
Identifiers
42270907What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.